Kumiko Lippold1, Bina Ali2. 1. Milkin Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue NW, Washington, DC 20052, United States. Electronic address: kmlippold@gwmail.gwu.edu. 2. Milkin Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue NW, Washington, DC 20052, United States; Pacific Institute for Research and Evaluation, 11720 Beltsville Drive, Suite 900 Calverton, MD 20705, United States. Electronic address: bali1@email.gwu.edu.
Abstract
BACKGROUND: From 1999 to 2017, more than 400,000 Americans died from a drug overdose death involving an opioid. Early surveillance studies have observed large variations in opioid-involved overdose deaths among different geographic regions and racial/ethnic groups. The purpose of this study was to characterize trends in racial/ethnic opioid-involved overdose deaths across metropolitan and non-metropolitan areas in the United States from 1999 to 2017. METHODS: The analysis used National Vital Statistics System data from 1999 to 2017 that were accessed through the CDC WONDER online database. Drug overdose deaths involving any opioid were identified using the International Classification of Diseases, Tenth Revision, codes and were represented as age-adjusted rates per 100,000 population. Joinpoint regression was used to examine trends in opioid-involved overdose deaths among racial/ethnic groups (non-Hispanic white, non-Hispanic black, Hispanic, non-Hispanic other) by metropolitan and non-metropolitan status (large metropolitan areas, medium-small metropolitan areas, and non-metropolitan areas). RESULTS: The annual age-adjusted death rates for drug overdose deaths that involved any opioid significantly increased for all racial/ethnic groups in metropolitan and non-metropolitan areas from 1999 to 2017. The largest average annual increases in rates occurred among non-Hispanic whites in non-metropolitan areas (13.6% increase per year) and medium-small metropolitan areas (12.3% increase per year), followed by non-Hispanic blacks in medium-small metropolitan areas (11.3% increase per year). CONCLUSIONS: The variations in opioid-involved overdose deaths among different racial/ethnic groups across geographic regions support the existence of multiple sub-epidemics in the current opioid overdose crisis and provide directions for targeted intervention efforts.
BACKGROUND: From 1999 to 2017, more than 400,000 Americans died from a drug overdose death involving an opioid. Early surveillance studies have observed large variations in opioid-involved overdose deaths among different geographic regions and racial/ethnic groups. The purpose of this study was to characterize trends in racial/ethnic opioid-involved overdose deaths across metropolitan and non-metropolitan areas in the United States from 1999 to 2017. METHODS: The analysis used National Vital Statistics System data from 1999 to 2017 that were accessed through the CDC WONDER online database. Drug overdose deaths involving any opioid were identified using the International Classification of Diseases, Tenth Revision, codes and were represented as age-adjusted rates per 100,000 population. Joinpoint regression was used to examine trends in opioid-involved overdose deaths among racial/ethnic groups (non-Hispanic white, non-Hispanic black, Hispanic, non-Hispanic other) by metropolitan and non-metropolitan status (large metropolitan areas, medium-small metropolitan areas, and non-metropolitan areas). RESULTS: The annual age-adjusted death rates for drug overdose deaths that involved any opioid significantly increased for all racial/ethnic groups in metropolitan and non-metropolitan areas from 1999 to 2017. The largest average annual increases in rates occurred among non-Hispanic whites in non-metropolitan areas (13.6% increase per year) and medium-small metropolitan areas (12.3% increase per year), followed by non-Hispanic blacks in medium-small metropolitan areas (11.3% increase per year). CONCLUSIONS: The variations in opioid-involved overdose deaths among different racial/ethnic groups across geographic regions support the existence of multiple sub-epidemics in the current opioid overdose crisis and provide directions for targeted intervention efforts.
Authors: Andrea M Lopez; Matthew Thomann; Zena Dhatt; Julieta Ferrera; Marwa Al-Nassir; Margaret Ambrose; Shane Sullivan Journal: Am J Public Health Date: 2022-04 Impact factor: 9.308
Authors: Xiao Zang; Alexandria Macmadu; Maxwell S Krieger; Czarina N Behrends; Traci C Green; Jake R Morgan; Sean M Murphy; Shayla Nolen; Alexander Y Walley; Bruce R Schackman; Brandon Dl Marshall Journal: Int J Drug Policy Date: 2021-09-03
Authors: Austin D Le; Yuemeng Li; Alicia Zhu; Jaiveer Singh; Jane Y Xu; Malathi Srinivasan; Latha P Palaniappan; Jin Long; Eric R Gross Journal: Br J Anaesth Date: 2022-07-02 Impact factor: 11.719
Authors: Katherine A Hirchak; Solmaz Amiri; Gordon Kordas; Oladunni Oluwoye; Abram J Lyons; Kelsey Bajet; Judith A Hahn; Michael G McDonell; Aimee N C Campbell; Kamilla Venner Journal: Subst Abuse Treat Prev Policy Date: 2022-05-25
Authors: Ximena A Levander; Kim A Hoffman; John W McIlveen; Dennis McCarty; Javier Ponce Terashima; P Todd Korthuis Journal: Addict Sci Clin Pract Date: 2021-12-11
Authors: Paul P Christopher; Catherine Stewart; William Manning; Bradley J Anderson; Alexander Woodruff; Jordanna Monteiro; Michael D Stein Journal: J Subst Abuse Treat Date: 2021-05-28